The majority of rare diseases affect children, most of whom have an underlying genetic cause for their condition. However, making a molecular diagnosis with current technologies …
JM Savatt, SM Myers - Frontiers in Pediatrics, 2021 - frontiersin.org
Neurodevelopmental disorders are the most prevalent chronic medical conditions encountered in pediatric primary care. In addition to identifying appropriate descriptive …
S Yohe, B Thyagarajan - Archives of pathology & …, 2017 - meridian.allenpress.com
Context.—Next-generation sequencing (NGS) is a technology being used by many laboratories to test for inherited disorders and tumor mutations. This technology is new for …
DR Adams, CM Eng - New England Journal of Medicine, 2018 - Mass Medical Soc
Clinical Next-Generation Sequencing—A Wild Frontier The technologies and chemistries underlying next-generation sequencing of DNA are evolving rapidly. This review describes …
K Stoll, S Kubendran, SA Cohen - American Journal of Medical …, 2018 - Wiley Online Library
Precision medicine aims to approach disease treatment and prevention with consideration of the variability in genes, environment, and lifestyle for each person. This focus on the …
S Lata, M Marasa, Y Li, DA Fasel… - Annals of internal …, 2018 - acpjournals.org
Background: The utility of whole-exome sequencing (WES) for the diagnosis and management of adult-onset constitutional disorders has not been adequately studied …
JE Petrikin, JA Cakici, MM Clark, LK Willig… - NPJ Genomic …, 2018 - nature.com
Genetic disorders are a leading cause of morbidity and mortality in infants in neonatal and pediatric intensive care units (NICU/PICU). While genomic sequencing is useful for genetic …
Genome‐scale sequencing creates vast amounts of genomic data, increasing the challenge of clinical sequence variant interpretation. The demand for high‐quality interpretation …
S Nambot, J Thevenon, P Kuentz, Y Duffourd… - Genetics in …, 2018 - nature.com
Purpose Congenital anomalies and intellectual disability (CA/ID) are a major diagnostic challenge in medical genetics—50% of patients still have no molecular diagnosis after a …